Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Shows Rheumatoid Arthritis Linked to Atrial Fibrillation

Sue Pondrom  |  August 16, 2011

It is well known by rheumatologists that heart disease is associated with the connective tissue diseases. Now, researchers at the University of Arkansas for Medical Sciences have shown that patients with rheumatoid arthritis (RA) are 60% more likely to develop atrial fibrillation than those without RA.

The findings were presented in May 2011 at the Heart Rhythm Society meeting in San Francisco, Calif. by one of the co-authors of the study, Abhishek Deshmukh, MD, a cardiology fellow at the University of Arkansas. He tells The Rheumatologist that the findings remind rheumatologists and patients with RA to keep watch on any symptoms of atrial fibrillation, such as racing heart and shortness of breath.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“This is an important study because it’s further evidence that these are systemic diseases that also can affect the heart,” comments Davis S. Pisetsky, MD, PhD, professor of medicine and immunology at Duke University Medical Center in Durham, N.C., and editor of The Rheumatologist.

Dr. Pisetsky says RA is associated with heart disease, and one manifestation of heart disease can be atrial fibrillation. “So, you might be expected to find an increase in A fib [atrial fibrillation] in people with diseases known to be associated. Nonetheless, this study is important because it’s how you interpret symptoms, what kind of work-up you would do, the medications you would give, and what other risk factors you would look for.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although he thinks it is interesting that the researchers picked up this association, he notes that medical science is already aware of the increase in heart disease in these patients. “So,” he notes, “is this because they had atherosclerosis, or is there an inflammatory process going on that’s different from atherosclerosis that would not be known?”

Dr. Deshmukh says that “despite adjusting for coronary artery disease, we still showed an association of atrial fibrillation and RA.”

Dr. Pisetsky points out that performing studies to pinpoint the cause of the inflammation would be difficult because there are not many ways to look at the tissue for inflammation of the heart or conducting system. “We have a lot of good ways to look at what happens to the vasculature of the heart, and if you saw atherosclerosis—which you’d expect to since these are conditions that have more atherosclerosis—you would likely ascribe the inflammation to atherosclerosis,” he says. “It would be hard to say there is something else going on. Having said that, regular cardiovascular disease has a lot of inflammation.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Clinical researchRheumatoid arthritis

Related Articles

    “The Pisetsky Effect”* Helps Mold The Rheumatologist into a Vibrant Publication

    December 12, 2011

    Colleagues and contributors share thoughts as the first editor’s tenure comes to a close

    Rheum After 5: Dr. David Pisetsky, Storyteller

    April 15, 2022

    David S. Pisetsky, MD, PhD, often tells people that science involves reading and writing as much as conducting experiments. No matter what discoveries are made in the lab, if they can’t be communicated well or put into context, he asks, how can they be used to advance the field and benefit patients? The recipient of…

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Year in Review: Rheumatic Disease Research in 2019

    November 20, 2019

    ATLANTA—Encouraging data on interleukin (IL) 23/IL-17 pathway drugs in psoriatic arthritis (PsA), JAK inhibitors in rheumatoid arthritis (RA) treatment and new evidence on physical activity and bone health in women were among the highlights of the 2019 ACR/ARP Annual Meeting’s Clinical Year in Review. Susan Manzi, MD, MPH, director of the Lupus Center for Excellence…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences